Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices

Matthew T Brown; Nanette K Wenger

doi:10.2174/011573403X307310240404062647

Less is More in Antithrombotic Therapy for Durable Left Ventricular Assist Devices

Curr Cardiol Rev. 2024;20(6):e150424228882. doi: 10.2174/011573403X307310240404062647.

Authors

Matthew T Brown¹, Nanette K Wenger¹

Affiliation

¹ Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia.

PMID: 38623981
PMCID: PMC11440322
DOI: 10.2174/011573403X307310240404062647

No abstract available

Keywords: Aspirin; HeartMate 3; atherosclerotic cardiovascular disease; left ventricular assist device; mechanical heart valves.; vitamin K antagonist.

Publication types

Editorial

MeSH terms

Anticoagulants / therapeutic use
Fibrinolytic Agents* / therapeutic use
Heart Failure* / therapy
Heart-Assist Devices*
Humans
Platelet Aggregation Inhibitors / therapeutic use
Thrombosis / etiology
Thrombosis / prevention & control

Substances

Fibrinolytic Agents
Platelet Aggregation Inhibitors
Anticoagulants